SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-22-004541
Filing Date
2022-05-03
Accepted
2022-05-03 17:07:56
Documents
2
Period of Report
2022-05-02

Document Format Files

Seq Description Document Type Size
1 form3-05032022_020539.html 3  
1 form3-05032022_020539.xml 3 12403
2 ex24-05032022_020540.htm EX-24 5735
  Complete submission text file 0001415889-22-004541.txt   19606
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Issuer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VISTAGEN THERAPEUTICS, INC. 343 ALLERTON AVE. SOUTH SAN FRANCISCO CA 94090
Business Address
Adler Reid G. (Reporting) CIK: 0001924908 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37761 | Film No.: 22888175